Genentech's Gazyva gains indication for idiopathic nephrotic syndrome

Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharma

2026/10/10

Philips investors’ move to probe company over 2021 recall denied by Dutch court

2026/10/10

Real estate stocks outperform broader markets

2026/10/10

Palantir Stock Closed at a Record After Barclays Set a $265 Target. Here’s What Q3 Has to Clear

2026/10/10